Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSamsung El.gdr Regulatory News (SMSN)

Share Price Information for Samsung El.gdr (SMSN)

Share Price is delayed by 15 minutes
Get Live Data
5,075.00    -515.00 (-9.21%)
Bid:
5,060.00
Ask:
5,065.00
Spread: 5.00 (0.099%)
Market Cap: $1.33t
SMSN Live PriceLast checked at - London Stock Exchange

Intraday Samsung El.gdr Share Chart

  • This share is an international stock.

Decision on Stock Split(Update)

16 Mar 2018 07:10

RNS Number : 9497H
Samsung Electronics Co. Ld
16 March 2018
 

Decision on Stock Split (Update)

 

Samsung Electronics Co., Ltd. (KS005930, KS005935, SMSN, SMSD) ("Samsung") today announced that the details of its stock split plan have been finalized. The stock split was originally announced on January 31, 2018. The updated details are set forth below:

 

 Information on decision regarding stock split

1. Details of Stock Split

Classification

Before Stock Split

After Stock Split

Face Value per Share (KRW)

5,000

100

Total Number of Shares Outstanding

Common Shares

128,386,494

6,419,324,700

Different Classes of Shares

18,072,580

903,629,000

2. Stock Split Schedule

Scheduled Date of Shareholders' Meeting

March 23, 2018

Period for Tendering Existing Shares

From

March 26, 2018

To

May 2, 2018 (originally April 26)

Scheduled Period of Trading Suspension

Three business days covering April 30 and May 2-3, 2018 as May 1 is a non-trading day (originally from April 25 to the day before scheduled listing date of new share certificates)

Period for Closing Shareholders' Registry

From

May 3, 2018 (originally April 27)

To

May 10, 2018 (originally May 14)

Scheduled Listing Date of New Share Certificates

May 4, 2018 (originally May 16)

3. Purpose of Stock Split

To increase the number of shares outstanding

4. Other important matters related to investment decision

1. This plan will be submitted to the upcoming meeting of shareholders scheduled on March 23, 2018.

2. The total number of shares outstanding reflects the number of shares that were cancelled on January 30, 2018 (712,000 common shares and 178,000 preferred shares).

3. The above schedules are subject to change in accordance with the voting results at the shareholder meeting.

4. The different classes of shares refers to preferred shares, and details are as follows:

1) Preferred shares have no voting rights.

2) Preferred shares are non-cumulative and pay 1% higher cash dividend per annum than do common shares, based on face value.

3) In the event of stock dividends or a capital increase with or without consideration, the conditions as stipulated in Article 8 of Samsung Electronics' Articles of Incorporation shall apply to newly issued preferred shares.

5. The Scheduled Period of Trading Suspension excludes the scheduled date of Samsung's first quarter earnings release (April 26) and the expiry dates of futures and options (May 10 and May 15, respectively) to minimize market impacts and for investor convenience.

6. The procedure of change listing shall take place before the issuance of new shares. Registered shareholders who deposited their shares to the Korea Securities Depository (KSD) through a brokerage firm can start transactions from May 4, 2018, the scheduled listing date of new share certificates, and holders of stock certificates can start transactions from May 11, 2018.

7. Holders of stock certificates can start transactions on the date of new share certificates if they deposit their shares to the KSD through a brokerage firm. (Contact your brokerage firm for inquiries related to deposit schedules or procedures.)

 

Other Information:

ž The above information is based on the laws of Korea and only applies to shares traded in the stock exchange of Korea.

Citibank, the depositary bank, will provide a separate notice regarding information related to depository receipts.

ž Number of Independent Directors Present at the BOD Meeting: 5

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCJFMRTMBMBMFP
Date   Source Headline
31st Oct 20249:02 amRNSDelisting and Listing of Stocks
31st Oct 20247:00 amRNSQuarterly Dividend for Third Quarter 2024
31st Oct 20247:00 amRNS2024 3Q Earnings Release
31st Oct 20247:00 amRNSAnnouncement of Capex Plan for FY2024
8th Oct 20247:00 amRNSNotice of 3Q 2024 Earning Release
8th Oct 20247:00 amRNS3Q 2024 Pre-Earnings Guidance
30th Aug 202410:52 amRNS2024 Half-year Business Report
31st Jul 20249:33 amRNSTransaction with Affiliate Company
31st Jul 20249:26 amRNSCharitable Contribution
31st Jul 20247:00 amRNSQuarterly Dividend for Second Quarter 2024
31st Jul 20247:00 amRNS2024 2Q Earnings Release
5th Jul 20247:55 amRNSNotice of 2Q 2024 Earnings Release Schedule
5th Jul 20247:45 amRNS2Q 2024 Pre-Earnings Guidance
28th Jun 20248:53 amRNSSustainability Report 2024
31st May 202410:23 amRNSCorporate Governance Report FY2023
31st May 20247:00 amRNS2024 1Q INTERIM BUSINESS REPORT
21st May 20249:34 amRNSNotice on Change of CEO
30th Apr 20248:10 amRNSTransactions with Affiliated Companies
30th Apr 20247:00 amRNSQuarterly Dividend for First Quarter 2024
30th Apr 20247:00 amRNS2024 1Q Earnings Release
30th Apr 20247:00 amRNS2023 Business Report
5th Apr 20247:11 amRNSNotice of 1Q 2024 Earnings Release Schedule
5th Apr 20247:00 amRNS1Q 2024 Pre-Earnings Guidance
20th Mar 20249:07 amRNSTransactions with Affiliated Companies
20th Mar 20249:05 amRNSResults of the 55th Annual General Meeting
21st Feb 20247:00 amRNSReference Material for 2024 AGM
20th Feb 20248:31 amRNSCharitable Contribution
19th Feb 20249:40 amRNS2023 Separate Financial Statements
19th Feb 20249:34 amRNS2023 Consolidated Financial Statements
31st Jan 20247:00 amRNSYear-End Dividend for FY2023
31st Jan 20247:00 amRNS2023 4Q Earning Release
31st Jan 20247:00 amRNSTransactions with Affiliated Companies
31st Jan 20247:00 amRNSShareholder Return Program for FY2024-2026
31st Jan 20247:00 amRNSAnnouncement of Capex Result for FY2023
9th Jan 20247:00 amRNSNotice of 4Q 2023 Earning Release
9th Jan 20247:00 amRNS4Q 2023 Pre-Earnings Guidance
1st Dec 202311:09 amRNSCharitable Contribution
30th Nov 20237:54 amRNSTransactions with Affiliated Companies
30th Nov 20237:34 amRNS2023 3Q Interim Business Report
6th Nov 20238:43 amRNSAnnouncement of Investor Relations Event
31st Oct 20237:21 amRNSTransactions with Affiliated Companies
31st Oct 20237:18 amRNSAnnouncement of Capex Plan for FY2023
31st Oct 20237:13 amRNSQuarterly Dividend for Third Quarter 2023
31st Oct 20237:10 amRNS2023 3Q Earning Release
11th Oct 20237:10 amRNSNotice of 3Q 2023 Earning Release
11th Oct 20237:04 amRNS3Q 2023 Pre-Earnings Guidance
21st Sep 20237:30 amRNS2022 Business Report
21st Sep 20237:29 amRNS2022 Separate Financial Statements
21st Sep 20237:29 amRNS2022 Consolidated Financial Statements
31st Aug 20238:15 amRNS2023 Half-year Business Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.